Relief of angina by nitroglycerine has been attributed to two possible mechanisms:
during angina pectoris induced by pacing. Coronary sinus blood flow by the continuous thermodilution method, femoral artery blood pressure, and lead V5 were recorded continuously. In 20 patients the procedure was repeated with injection into the right coronary artery. In none of the 25 patients did the intracoronary injection of nitroglycerin alleviate the angina during the 1-min observation period, whether injected into the obstructed artery or into the artery supplying collaterals to the obstructed artery. The intracoronary injection was ineffective despite a significant increase in coronary sinus blood flow in 14, lasting 26 sec on the average. This suggests that the increase in blood flow did not occur in the ischemic areas where it was needed, but in other areas where the arterioles were not maximally dilated by ischemia. This explanation is further supported by the fact that in five patients with very severe restriction of the left coronary artery system the coronary sinus blood flow failed to increase in response to intracoronary nitroglycerin during angina, but increased significantly in response to nitroglycerin after discontinuation of pacing and disappearance of angina. In six patients, 0.2 mg nitroglycerin injected intravenously 1 min following the intracoronary injection relieved the angina unaffected by the preceding intracoronary injection. The relief was associated with a fall in arterial blood pressure and coronary sinus blood flow. The study indicates that the direct action of nitroglycerin on the coronary bed plays little, if any, role in the antianginal effect of the drug, which appears to be due entirely to the action of the drug on the systemic circulation.
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Coronary sinus blood flow C Intravenous nitroglycerin A LTHOUGH nitroglycerin has been our most effective drug for the relief of .ontinuous thermodilution angina pectoris for nearly 100 years, the mechanism by which it acts is still uncertain. In previous studies on the mechanism of relief of angina pectoris by nitroglycerin, the drug was administered systemically by the sublingual route. Therefore, the operation of either or both mechanisms could not be determined with certainty.
FAILURE OF NITROGLYCERIN IN ANGINA
The present study was, therefore, designed in such a way that the effect of the direct action of nitroglycerin on the coronary bed in angina pectoris could be investigated in the absence of changes in the systemic circulation. This was achieved by direct intracoronary injection of nitroglycerin during pacing-induced angina in doses which were large enough to markedly increase the coronary sinus blood flow in subjects with normal coronary arteries, but too small to cause a change in systemic blood pressure. administration of the drug. However, the angina remained unaffected in these three patients as well. The angina was not relieved despite an increase in coronary sinus blood flow in 14 patients. The coronary sinus blood flow did not increase in the nine patients with marked narrowing of the main left coronary artery, or total or near total obstruction of the left anterior descending, and high-grade narrowing of the left circumflex artery. In five of these patients, the intracoronary injection of nitroglycerin was repeated after discontinuation of pacing and disappearance of angina. Under these circumstances the intracoronary injection did cause a significant increase in coronary sinus blood flow from a lower resting level (by 18-54%, 39% on the average). In no instance did coronary sinus blood flow exceed that associated with pacing (table 4) . Tracings of a typical case are shown in figure 1 .
Methods
In contrast to the intracoronary application, nitroglycerin injected intravenously in a dose of 0.2 mg relieved the angina, which was unaffected by the preceding intracoronary injection, in all six patients within 40-80 sec. The relief was preceded by a fall in arterial blood pressure and coronary sinus blood flow (table 5) . A typical case is presented in figure  2 . No complications were encountered during this study.
Discussion
The results of this study indicate that the direct action of nitroglycerin on the coronary arteries plays little, if any, role in the relief of angina pectoris by this drug. Although the amount of nitroglycerin injected into the coronary artery was M-X the sublingual dose, the concentration in the coronary vessels was many times higher than after sublingual administration. The effect of nitroglycerin on coronary sinus blood flow was maximal a few seconds after its intracoronary administration and lasted in patients with coronary artery disease for up to 50 sec. Since the drug was administered at the first signs of angina pectoris, complete or partial relief of the pain for at least a transient period could be expected if intracoronary nitroglycerin was The tracings show the effect of intracoronary nitroglycerin on coronary sinus blood flow during angina induced by pacing and at rest in patient 16, a 62-year-old male, with a history of an anteroseptal and inferior myocardial infarction and angina pectoris, with myocardial lactate production at rest, and severe disease of all three coronary arteries. (Left) Pacing at a rate of 101 beats/min induced angina which was not relieved by injection of 0.075 mg nitroglycerin into the left coronary artery. The coronary sinus blood flow (222 ml/min) did not increase following the intracoronary injection of nitroglycerin. (Right) The pacing was then discontinued and the intracoronary injection of 0.075 mg nitroglycerin repeated after disappearance of angina. This time the injection was followed by a marked increase in coronary sinus blood flow.
Abbreviations: CSBF -coronary sinus blood flow; TI -temperature of injectate; ABP = arterial blood pressure; NTG = nitroglycerin; HR = heart rate; =-injection of 3 ml of nitroglycerin: 2 ml into the dead space of the catheter and 1 ml into the coronary artery. 
